Atsuko Kimura
Overview
Explore the profile of Atsuko Kimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minote M, Sato W, Kimura K, Kimura A, Lin Y, Okamoto T, et al.
Immunol Med
. 2024 Mar;
47(3):151-165.
PMID: 38539051
'No evidence of disease activity (NEDA)', judged by clinical and radiological findings, is a therapeutic goal in patients with multiple sclerosis (MS). It is, however, unclear if distinct biological mechanisms...
2.
Kanazawa T, Sato W, Raveney B, Takewaki D, Kimura A, Yamaguchi H, et al.
Ann Neurol
. 2024 Mar;
95(6):1093-1098.
PMID: 38516846
Eomesodermin-expressing (Eomes) T-helper (Th) cells show cytotoxic characteristics in secondary progressive multiple sclerosis. We found that Eomes Th cell frequency was increased in the peripheral blood of amyotrophic lateral sclerosis...
3.
Amano E, Sato W, Kimura Y, Kimura A, Lin Y, Okamoto T, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Feb;
11(2):e200206.
PMID: 38350043
Background And Objectives: Neuromyelitis optica (NMO) is an autoimmune astrocytopathy mediated by anti-AQP4 antibody-producing B cells. Recently, a B-cell subset highly expressing CD11c and T-bet, originally identified as age-associated B...
4.
Matsuoka T, Araki M, Lin Y, Okamoto T, Gold R, Chihara N, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Oct;
11(1).
PMID: 37863660
Background And Objectives: Neuromyelitis optica spectrum disorder (NMOSD) is a disabling autoimmune neurologic disease. Anti-IL-6 receptor (IL-6R) therapy prevents relapses in patients with anti-aquaporin 4 (AQP4)-IgG-positive NMOSD; however, it remains...
5.
Namekata K, Tsuji N, Guo X, Nishijima E, Honda S, Kitamura Y, et al.
Cell Death Discov
. 2023 May;
9(1):166.
PMID: 37188749
Dedicator of cytokinesis 3 (DOCK3) is an atypical member of the guanine nucleotide exchange factors (GEFs) and plays important roles in neurite outgrowth. DOCK3 forms a complex with Engulfment and...
6.
Sato W, Noto D, Araki M, Okamoto T, Lin Y, Yamaguchi H, et al.
Ther Adv Neurol Disord
. 2023 Mar;
16:17562864231162153.
PMID: 36993937
Background: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that causes the damage to the myelin sheath as well as axonal degeneration. Individuals with MS...
7.
Kiyota N, Namekata K, Nishijima E, Guo X, Kimura A, Harada C, et al.
Neurosci Lett
. 2023 Feb;
799:137124.
PMID: 36780941
Visual disturbance after optic nerve injury is a serious problem. Attempts have been made to enhance the intrinsic ability of retinal ganglion cells (RGCs) to regenerate their axons, and the...
8.
Kogawa K, Matsuzaki Y, Kimura A, Minakawa S, Nakano H, Ito K, et al.
J Dermatol Sci
. 2022 Dec;
108(2):112-115.
PMID: 36509637
No abstract available.
9.
Nishijima E, Honda S, Kitamura Y, Namekata K, Kimura A, Guo X, et al.
Mol Ther
. 2022 Dec;
31(3):810-824.
PMID: 36463402
Activation of neurotrophic factor signaling is a promising therapy for neurodegeneration. However, the transient nature of ligand-dependent activation limits its effectiveness. In this study, we solved this problem by inventing...
10.
Guo X, Kimura A, Namekata K, Harada C, Arai N, Takeda K, et al.
Proc Natl Acad Sci U S A
. 2022 Feb;
119(6).
PMID: 35101972
Neuroinflammation is well known to be associated with neurodegenerative diseases. Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase that has been implicated in neuroinflammation, but its...